Coverage dated September 15, 2025 to September 18, 2025
CDC vaccine advisers delay controversial vote on hepatitis B vaccine
Headline from The Hill, on the newest of 2 developments
The CDC's vaccine advisers on the ACIP voted 11-1 to delay a recommendation on changes to the hepatitis B vaccine administered to newborns, a surprise greeted with relief by disease experts.
The Hill's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
RFK Jr.'s hand-picked panel of vaccine advisors is expected to vote to delay the hepatitis B shot for newborns. Doctors warn that could fuel a return of a disease virtually eradicated in U.S. kids.
A key federal vaccine advisory panel whose members were recently replaced by Health and Human Services Secretary Robert F. Kennedy Jr. is expected to vote to recommend delaying until age 4 the hepatitis B vaccine that’s currently given to newborns, according to two former senior Centers for Disease …
The CDC's vaccine advisers on the ACIP voted 11-1 to delay a recommendation on changes to the hepatitis B vaccine administered to newborns, a surprise greeted with relief by disease experts.
CNN By Brenda Goodman, CNN (CNN) — A meeting of advisers chosen by US Health and Human Services Secretary Robert F. Kennedy Jr. to guide US Centers for Disease Control and Prevention vaccine recommendations ended abruptly Thursday with a delayed vote on one vaccine, a vote against a vaccine used for…
The Centers for Disease Control and Prevention is not expected to change recommendations for hepatitis B vaccines in newborns, after its panel of advisers tabled Friday a much-awaited vote on the issue.
Top vaccine advisers hand-selected by Health Secretary Robert F. Kennedy Jr. voted Thursday to limit the use of a combination shot that protects against measles, mumps, rubella and chickenpox.
Health Secretary Robert F. Kennedy Jr.'s hand-picked panel of advisers will vote on their recommendations for the hepatitis B and COVID vaccines on the second day of the highly anticipated meeting.
Vaccine advisers to the US Centers for Disease Control and Prevention voted 11-1 to delay a vote on changes to a newborn hepatitis B shot. It was a surprise twist after a lengthy discussion on hepatitis B vaccines typically delivered to newborns shortly after birth.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
